(6,7) and fibrocartilage formation in vivo (8-10). Similarly, the limitations that affect chondrocyte of markers for hypertrophy thereby reducing their efficiency for optimal cartilage repair(13,14).
54
However, there are also report which demonstrate that chondrocytes exhibit positive stem cell 55 markers in culture(15,16).
56
Continued search for an optimal cell source led to a potential cell type residing within the 
73
The second category for comparison included markers considered to be expressed specifically by Since availability of OA cartilage is comparatively more than normal cartilage, and a dearth of 
86

Materials and Methods
87
Study design
88
The study protocol was approved by the Institutional Review board and carried out in accordance 89 to the guidelines laid down by the Ethics Committee. Human articular cartilage was harvested 90 from three normal (mean age: 22±4yrs) and OA (mean age: 63±7yrs) knee joints. Cartilage was 91 obtained from OA patients undergoing knee replacement surgery and from patients undergoing 
94
CPs and chondrocytes were isolated from superficial layer/full depth articular cartilage from 95 normal or OA knee joints. Both cell types were then cultured to passage (p) 10. Cells at different 96 time points in culture, namely p0, p1, p2, p3, p4, p5, p7 and p10 were characterized using FACS 97 for the three groups of surface markers mentioned before. Normal and OA cartilage derived CPs 98 and chondrocytes from p0 and p5 were compared for chondrogenic and hypertrophy markers by 99 subjecting them to RT PCR analysis. CPs and chondrocytes from p2 cultures were subjected to 100 tri-lineage differentiation (adipogenic, osteogenic and chondrogenic differentiation). In all, this 101 study contained 4 cell groups for comparison i.e. chondrocytes from normal cartilage,
102
chondrocytes from OA cartilage, CPs from normal cartilage and CPs from OA cartilage (Fig 1) .
103
Growth kinetics between the 4 groups was compared at each passage for estimation of cumulative 104 population doubling. ascorbic acid 62 μg/ml (Sigma), L-glutamine 2.5mM/L (Sigma), penicillin-streptomycin 100 117 IU/ml (Gibco) and amphotericin-B 2 μg/ml (Gibco). Medium was changed once every three days 118 (Fig 2) . At a confluence of 85-90%, cell harvest was carried out using 0.25% Trypsin-EDTA 119 (Gibco). 
Phenotyping-FACS
160
Chondrocytes and CPs from p0 to p10 were characterized by FACS. The studied antibodies against 161 human surface antigen were CD105, CD73, CD90, CD34, CD45, CD14, CD54, CD44, CD9,
162
CD106, CD29, CD151, CD49e, CD166 and CD146 (S1 Table) . The staining method followed reported as Mean ± SEM (S2 and S3 Table) .
170
RT-PCR
171
p0 and p5 chondrocytes and CPs from normal and OA joints were used for RT-PCR analysis. Total
172
RNA was isolated using TRIzol reagent (Sigma) as per manufacturer's instructions. The nucleic 173 acid concentration was quantified using Nanodrop 2000c spectrophotometer (ThermoScientific).
174
Visual assessment of total RNA was done by Image Quant 400 Gel Doc system (GB) for 28s:18s Table. 186
Live dead assay: Calcein AM-Ethidium homodimer
187
Cell viability was assessed for the four groups up to p5 on reaching a confluence of 2/3 rd of the The differentiated adipocytes were fixed with 10% formaldehyde for 1 hour, washed and stained
213
with Oil Red O (Sigma) (Fig 5A-5B ) and differentiated osteocytes were fixed with 70% ethanol 214 for 1 hour, washed and stained with Alizarin Red (Sigma) (Fig 5C-5D progressive increase in their growth kinetics upto p6 (Fig 4) .
239
FACS
240
FACS of both chondrocytes and CPs from normal and OA cartilage at various passages (24 hours 241 for chondrocytes and p0, p1, p2, p3, p4, p5, p7 and p10 for both) was performed to study surface 
245
In the first category a) CD105: all groups showed mild to high expression except for normal C at in normal CP P5 than in normal chondrocytes P5 (P=0.046, Fig 8D) P=0.037 respectively, Fig 9A) . 
291
Comparison across different cell types and cell source at p0 through p10. Fig 10 and Fig 11) . CD166 expression was higher in normal CP than in normal 300 chondrocytes at P0, P2 and P5(P=0.003, P=0.009 and P=0.037 respectively, Fig 11) . CD146 301 expression was higher in normal CP than in normal chondrocytes at P1 and P7 (P=0.013 and 302 P=0.003 respectively, Fig 11) . Similarly, the expression was higher in normal CP than OA C at 303 P1, P2 and P5 (P=0.004, P=0.023 and P=0.017 respectively, Fig 11) and OA CP at P1(P=0.002, no difference between the two populations when adipogenic potential was assessed (Fig 5A-B) .
379
Alizarin red staining indicative of mineralization used to assess osteogenic potential showed 380 positive staining in both cell groups with higher uptake seen with chondrocytes (Fig 5C-D) . Alcian blue when compared to their counterparts derived from OA cartilage (Fig 5E-F) . expression albeit higher in chondrocytes though not to a significant level (Fig 6D) . When 408 expression of negative MSC markers was assessed, we found that both cell population showed low 409 expression of CD45 and CD14 (Fig 7) . However, there was a significant difference in the 410 expression of CD34 as levels in chondrocyte groups were much higher than CP groups (Fig 7A; 411 Table 1 ). This leads us to suggest that CD34, a hematopoietic stem and progenitor cell marker(37)
412
although not expected to be expressed by cells derived from an avascular tissue like articular 413 cartilage, may be used to distinguish chondrocytes from CPs.
414
The second category considered was markers (CD54 and CD44) which specifically identify susceptibility for hypertrophy and a higher potential for chondrogenesis.
479
In conclusion, the study implies that CPs derived preferably from normal as opposed to OA joints 480 and isolated using markers with higher specificity would yield translatable results in terms of 481 enhanced chondrogenesis and reduced hypertrophy, both indispensable for the field of cartilage 482 regeneration.
483
